- We strive to provide complete care for our patients. Learn more about all the services we provide.
You are using an outdated browser. Please upgrade your browser to improve your experience.
A research study that will be used to evaluate the long-term safety of a specific MS treatment and other disease modifying therapies (DMT) in patients with MS newly started with the study medication Gilenya or Fingolimod.
Passages is a 5 year study that will provide an opportunity to learn more about the safety and satisfaction of MS Treatment with Fingolimod.
Patients receive a remuneration for their participation.
For more information contact Alonso Prusmack here.
Dr. Rosa Tang, MD, MPH, MBA
MS Eye Care at The University Eye Institute
4901 Calhoun Rd, UH Entrance 2
Houston, Texas 77204
Call to schedule an appointment or download this form and fax or e-mail it to us!
Kindly write PASSAGES study FOR Multiple Sclerosis patients under referral reason.
|Monday||9 AM||4 PM|
|Tuesday||9 AM||4 PM|
|Wednesday||9 AM||4 PM|
|Thursday||9 AM||4 PM|
|Friday||9 AM||4 PM|
|9 AM||9 AM||9 AM||9 AM||9 AM||Closed||Closed|
|4 PM||4 PM||4 PM||4 PM||4 PM||Closed||Closed|